# WALK-FORWARD ANALYSIS - COMPREHENSIVE AUDIT & VALIDATION

**Date**: 2026-01-15  
**Handoff To**: Experienced Quantitative Algorithmic Trading Analyst  
**Your Role**: Independent WFA auditor and validator  
**Objective**: Audit existing WFA, test all 3 systems, provide GO/NO-GO recommendations

---

## üéØ **YOUR MISSION**

You are an **experienced quant with deep WFA expertise**. Your job is to:

1. **Audit existing options WFA** (Phase 3) - verify methodology, check for errors
2. **Run WFA on all 3 systems** - options + equity (fresh tests)
3. **Compare your results** to existing tests
4. **Provide GO/NO-GO** on each system with confidence levels
5. **Recommend parameter tuning** if systems are salvageable
6. **Identify any methodological flaws** in existing work

**Critical**: Be **skeptical and rigorous**. If something doesn't pass muster, say so clearly.

---

## üìä **SYSTEMS TO TEST**

### **System 1: Premium Selling (Options)**
**Strategy**: Sell ATM options at RSI extremes, collect theta
- Entry: RSI <30 (sell put) or RSI >70 (sell call)
- Exit: 60% profit target, 21 DTE time exit, -150% stop loss
- Asset: SPY, QQQ
- **Existing WFA**: FAILED (Sharpe 0.35 vs 2.26 baseline)
- **Your Task**: Verify failure, test regime filter (vol <20%, RSI range >29)

### **System 2: Earnings Straddles (Options)**
**Strategy**: Buy ATM straddles around earnings
- Entry: 2 days before earnings
- Exit: 1 day after earnings (fixed 3-day hold)
- Asset: NVDA
- **Existing WFA**: PASSED (Sharpe 2.25, 58.3% win rate)
- **Your Task**: Verify robustness, check for data snooping

### **System 3: Daily Trend Hysteresis (Equity)**
**Strategy**: RSI hysteresis with adaptive thresholds
- Entry: RSI >55 (buy), RSI <45 (sell)
- Exit: RSI crosses 50 (mean reversion)
- Assets: MAG7 stocks (NVDA, AAPL, MSFT, GOOGL, AMZN, META, TSLA)
- **Existing Validation**: Parameter sweep on 2024-2026, NO WFA
- **Your Task**: Run proper WFA, validate robustness

---

## üî¨ **AUDIT CHECKLIST FOR EXISTING WFA**

### **Review Phase 3 Options WFA**

**Files to audit**:
- `research/backtests/options/phase3_walk_forward/wfa_premium_selling.py`
- `research/backtests/options/phase3_walk_forward/wfa_earnings_straddles.py`
- `research/backtests/options/phase3_walk_forward/wfa_results/*.csv`

**Questions to answer**:
1. ‚úÖ **Data integrity**: Is data fetched correctly? Any look-ahead bias?
2. ‚úÖ **Window design**: Are 6-month train/test windows appropriate?
3. ‚úÖ **Parameter optimization**: Is in-sample optimization done correctly?
4. ‚úÖ **Out-of-sample testing**: Are OOS tests truly blind?
5. ‚úÖ **Metrics calculation**: Is Sharpe calculated correctly?
6. ‚ö†Ô∏è **Overfitting risk**: Is parameter grid too large (243 combinations)?
7. ‚ö†Ô∏è **Sample size**: Are some windows too small (1-4 trades)?
8. ‚ö†Ô∏è **Regime filter**: Is the proposed filter (vol <20%, RSI >29) overfit?

**Expected findings**:
- Premium selling: Confirm failure or find methodology error
- Earnings straddles: Confirm success or identify hidden issues

---

## üß™ **YOUR WFA METHODOLOGY**

### **Standard WFA Framework**

```python
# Recommended approach

1. Data Period: 2020-2025 (5 years, multiple regimes)

2. Window Design:
   - Train: 6 months (minimum for statistical significance)
   - Test: 6 months (out-of-sample)
   - Anchored vs Rolling: Use ROLLING (more robust)
   - Minimum trades per window: 5 (reject windows with <5 trades)

3. Parameter Optimization:
   - Grid search on TRAINING data only
   - Optimize for Sharpe (not return - avoids overfitting)
   - Use cross-validation within training window if possible
   - Limit parameter combinations (max 50-100 to avoid overfitting)

4. Out-of-Sample Testing:
   - Apply optimized params to TEST data (blind)
   - Calculate: Sharpe, return, win rate, max DD, trade count
   - Track parameter stability across windows

5. Robustness Checks:
   - Parameter sensitivity: How much do results change with ¬±10% param change?
   - Regime analysis: Does strategy work in all market conditions?
   - Transaction costs: Are slippage/fees realistic?
   - Sample size: Are there enough trades for statistical significance?

6. Final Metrics:
   - Average OOS Sharpe across all windows
   - Sharpe standard deviation (consistency)
   - Worst-case OOS Sharpe (tail risk)
   - Parameter stability (how often do optimal params change?)
```

---

## üìã **TESTING REQUIREMENTS**

### **For Each System, Provide**:

1. **WFA Results Table**
   ```
   Window | Train Period | Test Period | OOS Sharpe | OOS Return | Win Rate | Trades
   W1     | 2020-01/06  | 2020-07/12  | X.XX       | +XX.X%     | XX%      | XX
   ...
   ```

2. **Parameter Stability Analysis**
   - Most common optimal parameters across windows
   - Parameter variation (std dev)
   - Recommendation: Use most common params or window-specific?

3. **Regime Analysis**
   - Correlation of performance with market vol, trend, etc.
   - Identify favorable/unfavorable regimes
   - Recommendation: Deploy always or with regime filter?

4. **Robustness Metrics**
   - Average OOS Sharpe
   - Sharpe std dev (lower = more consistent)
   - Worst-case OOS Sharpe
   - % of windows with Sharpe >1.0

5. **GO/NO-GO Decision**
   ```
   System: [Name]
   Decision: GO / NO-GO / CONDITIONAL
   Confidence: XX%
   
   Reasoning:
   - [Key finding 1]
   - [Key finding 2]
   
   If CONDITIONAL:
   - Required changes: [specific recommendations]
   - Re-test after changes: [yes/no]
   
   If NO-GO:
   - Fatal flaws: [list issues]
   - Salvageable?: [yes/no and how]
   ```

---

## üéØ **GO/NO-GO CRITERIA**

### **GO (Deploy with Confidence)**
- ‚úÖ Average OOS Sharpe ‚â• 1.5
- ‚úÖ Sharpe std dev < 0.5 (consistent)
- ‚úÖ Win rate ‚â• 55%
- ‚úÖ Works in ‚â•80% of windows (Sharpe >0.5)
- ‚úÖ Parameter stability (most common params work)
- ‚úÖ No obvious overfitting

### **CONDITIONAL (Deploy with Caution)**
- ‚ö†Ô∏è Average OOS Sharpe 1.0-1.5
- ‚ö†Ô∏è Sharpe std dev 0.5-1.0
- ‚ö†Ô∏è Win rate 50-55%
- ‚ö†Ô∏è Works in 60-80% of windows
- ‚ö†Ô∏è Moderate parameter instability
- ‚ö†Ô∏è Requires regime filter or parameter tuning

**Action**: Specify exact conditions for deployment

### **NO-GO (Do Not Deploy)**
- ‚ùå Average OOS Sharpe < 1.0
- ‚ùå Sharpe std dev > 1.0 (inconsistent)
- ‚ùå Win rate < 50%
- ‚ùå Works in <60% of windows
- ‚ùå High parameter instability
- ‚ùå Evidence of overfitting or data snooping

**Action**: Specify if salvageable and how, or abandon

---

## üîß **PARAMETER TUNING RECOMMENDATIONS**

If a system is CONDITIONAL or NO-GO but salvageable:

### **Tuning Framework**

1. **Identify the issue**
   - Low Sharpe? ‚Üí Adjust risk/reward parameters
   - Low win rate? ‚Üí Tighten entry criteria
   - High volatility? ‚Üí Add position sizing rules
   - Regime-dependent? ‚Üí Add regime filter

2. **Propose specific changes**
   ```
   Current: RSI 30/70, 60% profit target
   Proposed: RSI 25/75, 50% profit target
   Rationale: [explain why this should improve performance]
   ```

3. **Re-test on NEW data**
   - Don't re-optimize on same data (overfitting!)
   - Use 2019 data or 2026 YTD if available
   - Or use different asset (e.g., test SPY params on QQQ)

4. **Provide confidence level**
   - High (>80%): Strong theoretical reason + empirical support
   - Medium (50-80%): Empirical support but limited theory
   - Low (<50%): Speculative, needs more research

---

## üìä **COMPARISON TO EXISTING WORK**

### **Your Results vs Phase 3 Results**

Create comparison table:

| System | Metric | Phase 3 | Your WFA | Difference | Explanation |
|--------|--------|---------|----------|------------|-------------|
| Premium Selling | Avg OOS Sharpe | 0.35 | X.XX | ¬±X.XX | [Why different?] |
| Earnings Straddles | Avg OOS Sharpe | 2.25 | X.XX | ¬±X.XX | [Why different?] |

**If results differ significantly (>20%)**:
- Investigate methodology differences
- Check for bugs in either implementation
- Determine which result is more reliable
- Provide clear recommendation

---

## üö® **RED FLAGS TO WATCH FOR**

### **Overfitting Indicators**
- ‚ùå Optimal parameters change drastically between windows
- ‚ùå In-sample Sharpe >> out-of-sample Sharpe (>2x difference)
- ‚ùå Performance degrades over time (strategy decay)
- ‚ùå Too many parameters optimized (>5)
- ‚ùå Parameter grid too fine (e.g., RSI 29 vs 30 vs 31)

### **Data Issues**
- ‚ùå Look-ahead bias (using future data)
- ‚ùå Survivorship bias (only testing winners)
- ‚ùå Cherry-picked periods (avoiding bad regimes)
- ‚ùå Insufficient sample size (<20 trades total)
- ‚ö†Ô∏è **CRITICAL: NVDA 10-for-1 stock split on June 7, 2024**
  - Alpaca data is NOT split-adjusted
  - Pre-split: ~$1000/share, Post-split: ~$100/share
  - **Impact**: Any NVDA backtest crossing June 2024 will have distorted returns
  - **Solution**: Test 2020-2024 (pre-split) and 2024-2025 (post-split) separately
  - **OR**: Use split-adjusted data source
  - **Phase 3 approach**: Tested 2025 only (post-split) to avoid this issue

### **Methodology Issues**
- ‚ùå Optimizing on full dataset (no train/test split)
- ‚ùå Using same data for multiple tests (data snooping)
- ‚ùå Ignoring transaction costs
- ‚ùå Unrealistic assumptions (perfect fills, no slippage)

---

## üìÅ **DELIVERABLES**

### **Required Documents**

1. **WFA_AUDIT_REPORT.md**
   - Audit of existing Phase 3 work
   - Findings, issues, recommendations

2. **WFA_RESULTS_COMPREHENSIVE.md**
   - Your WFA results for all 3 systems
   - Detailed tables, charts, analysis

3. **GO_NO_GO_DECISIONS.md**
   - Clear GO/NO-GO for each system
   - Confidence levels
   - Deployment recommendations

4. **PARAMETER_TUNING_RECOMMENDATIONS.md** (if applicable)
   - Specific parameter changes
   - Rationale for each change
   - Expected improvement

5. **FINAL_DEPLOYMENT_PLAN.md**
   - Which systems to deploy
   - In what order
   - With what capital allocation
   - Risk management rules

### **Required Code**

1. **Your WFA scripts** (new, independent implementations)
   - `wfa_premium_selling_v2.py`
   - `wfa_earnings_straddles_v2.py`
   - `wfa_daily_trend_hysteresis.py`

2. **Analysis scripts**
   - `compare_wfa_results.py` (your results vs Phase 3)
   - `regime_analysis_comprehensive.py`
   - `parameter_sensitivity_analysis.py`

---

## üéì **CONTEXT & BACKGROUND**

### **What's Been Done**

**Phase 1** (Complete): Infrastructure setup, Black-Scholes implementation  
**Phase 2** (Complete): Initial validation on 2024-2025 data  
- Premium selling: Sharpe 2.26 (turned out to be overfit!)
- Earnings straddles: Sharpe ~1.5, 87.5% win rate

**Phase 3** (Complete): Walk-forward analysis on options  
- Premium selling: FAILED (Sharpe 0.35)
- Earnings straddles: PASSED (Sharpe 2.25)
- Regime analysis: Identified vol <20%, RSI range >29 as potential filter

**Phase 4** (YOUR TASK): Independent audit + equity WFA

### **Key Files to Review**

**Documentation**:
- `docs/options/README.md` - Options overview
- `docs/options/FINAL_SESSION_SUMMARY.md` - Complete journey
- `research/backtests/options/phase3_walk_forward/PHASE3_SUMMARY.md` - WFA findings
- `STATE.md` - System state (lines 838-858 have options summary)

**Code**:
- `research/backtests/options/phase3_walk_forward/` - All Phase 3 WFA code
- `research/backtests/options/phase2_validation/` - Original backtests
- `src/options/features.py` - Black-Scholes implementation

**Results**:
- `research/backtests/options/phase3_walk_forward/wfa_results/` - All WFA output

---

## üéØ **SUCCESS CRITERIA**

Your audit is successful if:

1. ‚úÖ **Methodology is sound** - WFA done correctly or flaws identified
2. ‚úÖ **Results are reproducible** - Your tests match or explain differences
3. ‚úÖ **Decisions are clear** - Unambiguous GO/NO-GO with rationale
4. ‚úÖ **Recommendations are actionable** - Specific next steps
5. ‚úÖ **Risk is quantified** - Confidence levels on all decisions

---

## üí° **ADDITIONAL RECOMMENDATIONS**

### **Best Practices**

1. **Be conservative** - Better to reject a good strategy than deploy a bad one
2. **Demand statistical significance** - Minimum 20 trades, preferably 50+
3. **Test transaction costs** - Double slippage assumptions, see if still profitable
4. **Check regime dependence** - Strategy should work in multiple market conditions
5. **Validate assumptions** - Are IV estimates realistic? Are fills achievable?

### **When in Doubt**

- **NO-GO is safer than CONDITIONAL**
- **Request more data** if sample size is insufficient
- **Recommend paper trading** before live deployment
- **Flag any concerns** even if not fatal

---

## üìû **QUESTIONS TO ANSWER**

At the end of your analysis, you should be able to answer:

1. **Is the existing Phase 3 WFA methodology sound?**
2. **Do premium selling results (Sharpe 0.35) hold up under scrutiny?**
3. **Do earnings straddles results (Sharpe 2.25) hold up under scrutiny?**
4. **Should we deploy the regime filter for premium selling?**
5. **How robust is the daily trend hysteresis system (equity)?**
6. **What is the recommended portfolio allocation across systems?**
7. **What is the expected live performance (conservative estimate)?**
8. **What are the top 3 risks to monitor?**

---

## üöÄ **FINAL DELIVERABLE**

**One-page executive summary**:

```
WALK-FORWARD ANALYSIS - FINAL VERDICT

Systems Tested: 3 (Premium Selling, Earnings Straddles, Daily Trend Hysteresis)

GO Systems:
- [System name]: Sharpe X.XX, Confidence XX%, Deploy with $XX,XXX

CONDITIONAL Systems:
- [System name]: Sharpe X.XX, Confidence XX%, Deploy IF [conditions]

NO-GO Systems:
- [System name]: Sharpe X.XX, Fatal flaw: [issue]

Recommended Portfolio:
- XX% [System 1]
- XX% [System 2]
- XX% Cash (until conditions met)

Expected Performance:
- Annual Return: XX-XX% (conservative)
- Sharpe: X.X-X.X
- Max Drawdown: XX-XX%

Top Risks:
1. [Risk 1]
2. [Risk 2]
3. [Risk 3]

Next Steps:
1. [Action 1]
2. [Action 2]
3. [Action 3]

Confidence in Recommendations: XX%
```

---

**Good luck, quant! Be rigorous, be skeptical, and give us the truth.** üéØ

---

**END OF HANDOFF**  
**Date**: 2026-01-15  
**Prepared by**: Phase 3 WFA Team  
**For**: Independent Quantitative Analyst
